Sun Pharmaceutical Industries Ltd on January 31 reported an 11% rise in its consolidated net profit to Rs 2,058.80 crore in the December quarter. The firm reported a profit of Rs 1,852.50 crore last year in the same quarter.
Consolidated net sales for the quarter increased 11.41% from a year ago to Rs 9,814.17 crore. Total cost advanced 12% to Rs 7,829.38 crore. Operating EBITDA margin declined sharply to 17.12% in the quarter from 20.43% a quarter ago and 20.97% a year ago.
At 2.07pm, Sun Pharma stock fell 0.47% to Rs 823 a share on the BSE.
(This is developing story and addition will be done soon)
